Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

ABSTRACT: The objective is to investigate the efficacy and safety of envafolimab combined with recombinant human endostatin (endostatin) in the treatment of MSS-type colorectal cancer patients with recurrence or metastasis after failure of second-line standard therapy.

DISEASE(S): Colorectal Neoplasms

PROVIDER: 2749194 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR